ACAD vs EIX
ACADIA Pharmaceuticals Inc (ACAD) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ACAD and EIX stock pages for the full models.
Not investment advice.